SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 17 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy
Predictive Oncology (NASDAQ: POAI) announced the pricing of two concurrent private placement transactions totaling approximately…
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Unveils 2026 MVR Series With First HVAC-Equipped Electric Carts
Massimo Group (NASDAQ: MAMO) announced the launch of its 2026 MVR Series, introducing the MVR HVAC…
-
QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Signs LOI to Acquire BioSpark AI Technologies
Fifty 1 Labs (OTC: FITY) announced it has signed a Letter of Intent to acquire…